Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierluigi Viale

Showing results (81-90 of 466) with videos related to

Pageof 47
Sort By:
World Journal of Transplantation|July 1, 2016
Ventilator associated pneumonia following liver transplantation: Etiology, risk factors and outcomeAntonio Siniscalchi, Lucia Aurini, Beatrice Benini, et al.
The New Microbiologica|February 28, 2023
Severe Escherichia coli infections in critical adult patients: two case reports and genomic analysisStefano Amadesi, Giulio Virgili, Elisa Marchionni, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2023
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2025
Efficacy and Safety of Dolutegravir/Lamivudine in Antiretroviral Therapy-Naive People Living With HIV-1 and With High-Level ViremiaLeonardo Calza, Vincenzo Colangeli, Maddalena Giglia, et al.
Antibiotics (Basel, Switzerland)|September 27, 2025
Rapid Emergence of Cefiderocol Resistance Associated with Mutation of <i>EnvZ</i> Gene in a VIM-Producing ST307 <i>Klebsiella pneumoniae</i> StrainSimone Ambretti, Benedetta Secci, Raul Cetatean, et al.
Infectious Diseases (London, England)|December 27, 2019
No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-upLeonardo Calza, Marco Borderi, Vincenzo Colangeli, et al.
International Journal of STD & AIDS|August 11, 2023
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experienceLeonardo Calza, Vincenzo Colangeli, Giulia Pensalfine, et al.
Scandinavian Journal of Infectious Diseases|August 6, 2002
Linezolid for the treatment of central nervous system infections in neurosurgical patientsPierluigi Viale, Leonardo Pagani, Francesco Cristini, et al.
Medical Mycology Case Reports|June 25, 2021
<i>Pseudozyma aphidis</i> bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literatureAngelo Maccaro, Renato Pascale, Andrea Liberatore, et al.
World Journal of Hepatology|January 2, 2018
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antiviralsViola Guardigni, Lorenzo Badia, Matteo Conti, et al.
Pageof 47

Showing results (81-90 of 466) with videos related to

Sort By:
Pageof 47
World Journal of Transplantation|July 1, 2016
Ventilator associated pneumonia following liver transplantation: Etiology, risk factors and outcomeAntonio Siniscalchi, Lucia Aurini, Beatrice Benini, et al.
The New Microbiologica|February 28, 2023
Severe Escherichia coli infections in critical adult patients: two case reports and genomic analysisStefano Amadesi, Giulio Virgili, Elisa Marchionni, et al.
Antimicrobial Agents and Chemotherapy|October 16, 2023
Could an optimized joint pharmacokinetic/pharmacodynamic target attainment of continuous infusion ceftazidime-avibactam be a way to avoid the need for combo therapy in the targeted treatment of deep-seated DTR Gram-negative infections?Milo Gatti, Matteo Rinaldi, Cecilia Bonazzetti, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2025
Efficacy and Safety of Dolutegravir/Lamivudine in Antiretroviral Therapy-Naive People Living With HIV-1 and With High-Level ViremiaLeonardo Calza, Vincenzo Colangeli, Maddalena Giglia, et al.
Antibiotics (Basel, Switzerland)|September 27, 2025
Rapid Emergence of Cefiderocol Resistance Associated with Mutation of <i>EnvZ</i> Gene in a VIM-Producing ST307 <i>Klebsiella pneumoniae</i> StrainSimone Ambretti, Benedetta Secci, Raul Cetatean, et al.
Infectious Diseases (London, England)|December 27, 2019
No progression of subclinical atherosclerosis in HIV-infected patients starting an initial regimen including tenofovir alafenamide/emtricitabine plus raltegravir, dolutegravir or elvitegravir/cobicistat during a two-year follow-upLeonardo Calza, Marco Borderi, Vincenzo Colangeli, et al.
International Journal of STD & AIDS|August 11, 2023
Doravirine/lamivudine/tenofovir disoproxil fumarate in virologically suppressed people living with HIV: A real-life experienceLeonardo Calza, Vincenzo Colangeli, Giulia Pensalfine, et al.
Scandinavian Journal of Infectious Diseases|August 6, 2002
Linezolid for the treatment of central nervous system infections in neurosurgical patientsPierluigi Viale, Leonardo Pagani, Francesco Cristini, et al.
Medical Mycology Case Reports|June 25, 2021
<i>Pseudozyma aphidis</i> bloodstream infection in a patient with aggressive lymphoma and a history of intravenous drug use: Case report and review of the literatureAngelo Maccaro, Renato Pascale, Andrea Liberatore, et al.
World Journal of Hepatology|January 2, 2018
Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antiviralsViola Guardigni, Lorenzo Badia, Matteo Conti, et al.
Pageof 47